Award notice, first published as combined synopsis and solicitation
Internet Monitoring Services of FDA Related Products
75F40124Q00348
Food and Drug Administration, FDA Office of Regulatory Affairs. Other Computer Related Services.
Awarded
$2,538,016.00 obligated so far on USAspending
Description
As published on SAM.gov with the combined synopsis and solicitation of July 18, 2024.
**AMENDMENT 2
Please see updated Attachment_A_SOW_Amendment2, Attachment_B_PricingExcelWorkbook_Amendment2, Attachment_C_SOL_RFQ_Amendment2, and QA_FDA OCI Internet Monitoring Services_75F40124Q00348 - The purpose of this amendment is to provide responses to questions submitted by interested vendors as well as revise ALL attachments associated.** FDA is responsible for regulating products to ensure the safety of foods, prescription and over-the-counter drugs, biological products such as vaccines and blood, medical devices, cosmetics, radiation-emitting products, and more.
Since 1993, Office of Criminal Investigation (OCI) has investigated thousands of criminal schemes involving the distribution of potentially dangerous FDA-regulated products.
These investigations have involved a wide variety of criminal conduct, including street level distribution of counterfeit, unapproved, and designer drugs, major organized illicit diversion of prescription drugs, fraudulent schemes involving ineffective AIDS, cancer, and Alzheimer cures, large scale product substitution conspiracies, application and clinical investigator fraud, and health frauds involving harmful FDA-regulated drugs and medical devices.
As FDA’s criminal law enforcement arm, OCI protects the American public by conducting criminal investigations of illegal activities involving FDA-regulated products, arresting those responsible, and bringing them before the Department of Justice for prosecution. The Food and Drug Administration (FDA) requires contractor support to further its on-going efforts to counter the widespread illicit trafficking and/or marketing of FDA-regulated products over the Internet.
These products include prescription drugs; dietary supplements; tobacco; medical devices; blood and biologics; vaccines; cosmetics; radiation-emitting products; animal and veterinary medicines; and foods.
The contract, on USAspending
Federal procurement data the awarding office reported to FPDS, matched to this solicitation by its number.
- Recipient
- S-3 Research LLC
- UEI
- LELZHK767GF3
- CAGE
- 86LK0
- Vendor location
- San Diego, CA
- Contract
- 75F40124P00395, purchase order
- Obligated
- $2,538,016.00, potential $6,842,784
- Actions
- 4 between September 27, 2024 and February 9, 2026
- Competition
- Competed Under SAP, 10 offers received
- Set-aside reported
- No Set Aside Used.
- Described as
- Oci - Internet Monitoring Services
- Match
- solicitation number 75F40124Q00348 equals the FPDS solicitation identifier; same sub-agency 7524 (high confidence)
- Record
- USAspending award page
Publications
Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.
July 8, 2024
Combined synopsis and solicitation
Due July 18, 2024 at 3:00 PM EDT. SAM.gov, notice 7dadee94a1b746109cbe3df7fc5dea91
July 9, 2024
Combined synopsis and solicitation
Due July 18, 2024 at 3:00 PM EDT. SAM.gov, notice 91cb00bcb96e41db9e8e1c1b9fbbb4f5
July 18, 2024
Combined synopsis and solicitation
Due July 22, 2024 at 10:00 AM EDT. SAM.gov, notice 4bdede173938452884e7c2d482f729a8
October 1, 2024
Award notice, originally combined synopsis and solicitation
Awarded to S-3 RESEARCH LLC San Diego for $6,842,784. SAM.gov, notice 778f8cd9399a48e2ae16075261337c2c
Points of contact
- Brian WodziszBrian.Wodzisz@fda.hhs.gov3017967376
- Michelle Dacanaymichelle.dacanay@fda.hhs.gov301-796-0447